SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medico Remedies soars on bagging order worth Rs 73.23 crore

20 Jan 2026 Evaluate

Medico Remedies is currently trading at Rs. 48.46, up by 1.28 points or 2.71% from its previous closing of Rs. 47.18 on the BSE.

The scrip opened at Rs. 45.11 and has touched a high and low of Rs. 50.07 and Rs. 45.00 respectively. So far 16208 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 79.78 on 06-Feb-2025 and a 52 week low of Rs. 35.00 on 12-Aug-2025.

Last one week high and low of the scrip stood at Rs. 50.07 and Rs. 45.00 respectively. The current market cap of the company is Rs. 402.80 crore.

The promoters holding in the company stood at 61.38%, while Institutions and Non-Institutions held 0.31% and 38.30% respectively.

Medico Remedies has secured government supply order worth around Rs 73.23 crore from Uttar Pradesh Medical Supplies Corporation. The order is for supply of Azithromycin 500gm (tablets). The order is expected to be completed by October 31, 2026.

Uttar Pradesh Medical Supplies Corporation is the entity formed by Government of Uttar Pradesh (GoUP), is responsible for the centralized purchase and distribution of medicines, health supplies for GoUP and is committed to provide timely and effective Health Care Services to the people of Uttar Pradesh.

Medico Remedies is a leading manufacturer and exporter of pharmaceutical formulations including tablets, capsules and suspensions.

Medico Remedies Share Price

38.89 0.73 (1.91%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×